|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/11 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| C12N 5/10 | (2006.01) | ||
| C07K 14/47 | (2006.01) | ||
| C07K 16/30 | (2006.01) | ||
| C07K 16/32 | (2006.01) | ||
| A61K 48/00 | (2006.01) | ||
| C07K 16/18 | (2006.01) | ||
| G01N 33/574 | (2006.01) |
| (11) | Number of the document | 2399996 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11007307.9 |
| Date of filing the European patent application | 2003-11-21 | |
| (97) | Date of publication of the European application | 2011-12-28 |
| (45) | Date of publication and mention of the grant of the patent | 2017-09-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 10254601 | 2002-11-22 | DE |
| (72) |
Sahin, Ugur, DE
Türeci, Özlem, DE
Koslowski, Michael, DE
|
| (73) |
Ganymed Pharmaceuticals GmbH,
An der Goldgrube 12, 55131 Mainz,
DE
|
| (54) | DIFFERENTIELL IN TUMOREN EXPRIMIERTE GENPRODUKTE UND DEREN VERWENDUNG |
| IN TUMOURS DIFFERENTIALLY EXPRESSED GENE PRODUCTS AND USE OF THE SAME. |